Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.85 USD | 0.00% | +4.42% | -38.95% |
Apr. 30 | Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.95% | 236M | D+ | ||
-18.94% | 18.18B | A | ||
-42.48% | 2.84B | C+ | ||
+22.69% | 1.94B | - | ||
-1.56% | 1.64B | - | ||
+32.76% | 1.33B | B+ | ||
-17.41% | 953M | - | ||
-22.25% | 891M | - | C- | |
+4.49% | 865M | - | ||
+25.94% | 543M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MASS Stock
- Ratings 908 Devices Inc.